Effectiveness of prokinetic agents against diseases external to the gastrointestinal tract

Journal of Gastroenterology and Hepatology (Australia)

Volumn 24, Issue 4, 2009, Pages 537-546

  Hiyama, Toru ^a   Yoshihara, Masaharu ^a   Tanaka, Shinji ^b   Haruma, Ken ^c   Chayama, Kazuaki ^d  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^c KAWASAKI MEDICAL SCHOOL   (Japan)

^d HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Effectiveness; GI tract; Prokinetic agents; Review

Indexed keywords

ANALGESIC AGENT; BACLOFEN; BETHANECHOL; CHLORPROMAZINE; CISAPRIDE; CLOMIFENE CITRATE; DIHYDROERGOTAMINE; DOMPERIDONE; ERYTHROMYCIN; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYZINE; IBUPROFEN; ITOPRIDE; KETOROLAC; LEVODOPA; METHOHEXITAL; METOCLOPRAMIDE; MOSAPRIDE CITRATE; NEOMYCIN; NORFLOXACIN; OMEPRAZOLE; PETHIDINE; PROCHLORPERAZINE; PROKINETIC AGENT; PROTON PUMP INHIBITOR; RANITIDINE; TEGASEROD; TRIMEBUTINE; UNINDEXED DRUG; VALPROIC ACID;

ADJUVANT THERAPY; AMENORRHEA; ANESTHESIA; ANOREXIA NERVOSA; ARTICLE; ASPIRATION PNEUMONIA; ASTHMA; BACTERIAL PERITONITIS; BLADDER DISEASE; CHOLELITHIASIS; CLINICAL TRIAL; COUGHING; DETRUSOR AREFLEXIA; DIABETES MELLITUS; DIABETIC CYSTOPARESIS; DRUG ABSORPTION; DRUG EFFECT; DRUG EFFICACY; FEEDING; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL TRACT; GILLES DE LA TOURETTE SYNDROME; HICCUP; HUMAN; INTENSIVE CARE; LACTATION; LARYNX DISORDER; MEDLINE; MIGRAINE; NAUSEA; PARKINSON DISEASE; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; SLEEP DISORDER; SPINAL CORD INJURY; STOMACH DISEASE; STOMACH MOTILITY; STOMACH PARESIS; SYSTEMATIC REVIEW; TUBE FEEDING; URINARY TRACT DISEASE; URINE RETENTION; UTERINE CERVIX CANCER;

EID: 63849228546     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2009.05780.x     Document Type: Article

References (149)

1. Hiyama T, Yoshihara M, Tanaka S, Haruma K, Chayama K. Strategy for treatment of nonerosive reflux disease in Asia. World J. Gastroenterol. 2008 14 : 3123 8.
2. McCallum RW, Cynshi O, Investigative T. Clinical trial: effect of mitemcinal (a motilin agonist) on gasric emptying in patients with gastroparesis-a ranodomized, multicentre, placebo-controlled study. Aliment. Pharmacol. Ther. 2007 26 : 1121 30.
3. Traut U, Brugger L, Kunz R et al. Systemic prokinetic pharmacologic treatment for postoperative adynamic ileus following abdominal surgery in adults. Cochrane Database Syst. Rev. 2008 1 CD004930.
4. Shende D, Mandel NG. Efficacy of ondansetron and metoclopramide for preventing postoperative emesis following strabismus surgery in children. Anaesthesia 1997 52 : 496 500.
5. Scuderi PE, Weaver RG Jr., James RL, Mims G, Elliott WG, Weeks DB. A randomized, double-blind, placebo controlled comparison of droperidol, ondansetron, and metoclopramide for the prevention of vomiting following outpatient strabismus surgery in children. J. Clin. Anesth. 1997 9 : 551 8.
6. Bach-Styles T, Martin-Sheridan D, Hughes C, Kaufman S. Comparison of ondansetron, metoclopramide, and placebo in the prevention of postoperative emesis in children undergoing ophthalmic surgery. CRNA 1997 8 : 152 6.
7. Smith PV, Walton DS. Prevention of vomiting after general anesthesia for pediatric ophthalmic surgery. AANA J. 2001 69 : 39 43.
8. Tonimi M, Cipollina L, Poluzzi E, Crema F, Corraza GR, De Ponti F. Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics. Aliment Pharmacol. Ther. 2004 19 : 379 90.
9. Halter F, Staub P, Hammer B, Guyot J, Miazza BM. Study with two prokinetics in functional dyspepsia and GORD: domperidone vs. cisapride. J. Physiol. Pharmacol. 1997 48 : 185 92.
10. Delvaux M, Wingate D. Trimebutine: mechanism of action, effects on gastrointestinal function and clinical results. J. Int. Med. Res. 1997 25 : 225 46.
11. Chen JD, Ke MY, Lin XM, Wang Z, Zhang M. Cisapride provides symptomatic relief in functional dyspepsia associated with gastric myoelectrical abnormality. Aliment. Pharmacol. Ther. 2000 14 : 1041 7.
12. Evans BW, Clark WK, Moore DJ, Whorwell PJ. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation. Cochrane Database Syst. Rev. 2007 4 CD003960.
13. Curran MP, Robinson DM. Mosapride in gastrointestinal disorders. Drugs 2008 68 : 981 91.
14. Tonini M, De Ponti F, Di Nucci A, Crema F. Review article: cardiac adverse effects of gastrointestinal prokinetics. Aliment. Pharmacol. Ther. 1999 13 : 1585 91.
15. 2-receptor antagonist. Ann. Pharmacother. 1999 33 : 429 40.
16. Reddymasu SC, Soykan I, McCallum RW. Domperidone: review of pharmacology and clinical applications in gastroenterology. Am. J. Gastroenterol. 2007 102 : 2036 45.
17. De Maeyer JH, Lefebvre RA, Schuurkes JA. 5-HT4 receptor agonists: similar but not the same. Neurogastroenterol. Motil. 2008 20 : 99 102.
18. Hiyama T, Yoshihara M, Matsuo K et al. Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia. J. Gastroentrol. Hepatol. 2007 22 : 304 10.
19. Hiyama T, Yoshihara M, Matsuo K et al. Treatment of functional dyspepsia with serotonin agonists: a meta-analysis of randomized controlled trials. J. Gastroenterol. Hepatol. 2007 22 : 1566 70.
20. Rits MA, Fraser R, Tam W, Dent J. Impacts and patterns of disturbed gastrointestinal function in critically ill patients. Am. J. Gastroenerol. 2000 95 : 3044 52.
21. Kao CH, ChangLai SP, Chieng PU, Yen TC. Gastric emptying in head-injured patients. Am. J. Gastroenterol. 1998 93 : 1108 12.
22. Doherty WL, Winter B. Prokinetic agents in critical care. Crit. Care 2003 7 : 206 8.
23. Booth CM, Heyland DK, Paterson WG. Gastrointestinal promotility drugs in the critical setting: a systematic review of the evidence. Crit. Care Med. 2002 30 : 1429 35.
24. Whatley K, Turner WW Jr., Dey M, Leonard J, Guthrie M. When does metoclopramide facilitate transpyloric intubation? JPEN J. Parenter. Enteral. Nutr. 1984 8 : 679 81.
25. Heiselman DE, Hofer T, Vidovich RR. Enteral feeding tube placement success with intravenous metoclopramide administration in ICU patients. Chest 1995 107 : 1686 8.
26. Luchtefeld W, Shapiro M, Durham R. Efficacy of metoclopramide in fascilitating duodenal placement of small bore feeding tubes in trauma patients. JPEN J. Parenter. Enteral. Nutr. 1994 18 : 31S.
27. Paz HL, Weinar M, Sherman MS. Motility agents for the placement of weighted and unweighted feeding tubes in critically ill patients. Intensive Care Med. 1996 22 : 301 4.
28. Kalliafas S, Choban PS, Ziegler D, Drago S, Flancbaum L. Erythromycin facilitates postpyloric placement of nasoduodenal feeding tubes in intensive care unit patients: randomized, double-blinded, placebo-controlled trial. JPEN J. Parenter. Enteral. Nutr. 1996 20 : 385 8.
29. Griffith DP, McNalley AT, Battey CH. Efficacy of erythromycin for small intestinal feeding tube placement in ICU patients: a double-blind, randomized, placebo-controlled study. JPEN J. Parenter. Enteral. Nutr. 1991 21 : S3.
30. Williams A. The effect of cisapride on gastric stasis in intensive care patients. Br J Intensive Care 1996 6 : 186 93.
31. Goldhill DR, Toner CC, Tarling MM, Baxter K, Withington PS, Whelpton R. Double-blind, randomized study of the effect of cisapride on gastric emptying in critically ill patients. Crit. Care Med. 1997 25 : 447 51.
32. Spapen H, Duinslaeger L, Diltoer M, Gillet R, Bossuyt A, Huyghens LP. Gastric emptying in critically ill intensive-care patients is accelerated by adding cisapride to a standard enteral feeding protocol: results of a prospective, randomized, controlled trial. Crit. Care Med. 1995 23 : 481 5.
33. Heyland DK, Tougas G, Cook DJ, Guyatt GH. Cisapride improves gastric emptying in mechanically ventilated, critically ill patients. A randomized, double-blind trial. Am. J. Respir. Crit. Care Med. 1996 154 : 1678 83.
34. Dive A, Miesse C, Galanti L et al. Effect of erythromycin on gastric motility in mechanically ventilated critically ill patients: a double-blind, randomized, placebo-controlled study. Crit. Care Med. 1995 23 : 1356 62.
35. Chapman MJ, Fraser RJ, Kluger MT, Buist MD, De Nichilo DJ. Erythromycin improves gastric emptying in critically ill patients intolerant of nasogastric feeding. Crit. Care Med. 2000 28 : 2334 7.
36. Dive A, Garrino M, Nizet H et al. Gastric microbial overgrowth and retrograde colonization of the ventilated lung: effect of a digestive prokinetic therapy. In 7th European Congress of Intensive Care Medicine. Insbruck, Austria, June 14-17, 1994, p. 757.
37. Jooste CA, Mustoe J, Collee G. Metoclopramide improves gastric motility in critically ill patients. Intensive Care Med. 1999 25 : 464 8.
38. MacLaren R, Hall RI, Patrick WD. Cisapride versus metoclopramide for facilitating gastric emptying and tolerance to intragastric nutrition. Crit. Care Med. 2000 28 (Suppl A104.
39. Calcroft RM, Joynt G, Hung V. Gastric emptying in critically ill patients: a randomized, blinded, prospective comparison of metoclopramide with placebo. Intensive Care Med. 1997 23 (Suppl S138.
40. MacLaren R, Kuhl DA, Gervasio JM et al. Sequential single doses of cisapride, erythromycin, and metoclopramide in critically ill patients intolerant to enteral nutrition: a randomized, placebo-controlled, crossover study. Crit. Care Med. 2000 28 : 438 44.
41. Yavagal DR, Karnad DR, Oak JL. Metoclopramide for preventing pneumonia in critically ill patients receiving enteral tube feeding: a randomized controlled trial. Crit. Care Med. 2000 28 : 1408 11.
42. Davies AR, Ballomo R. Establishment of enteral nutrition: prokinetic agents and small bowel feeding tubes. Curr. Opin. Crit. Care 2004 10 : 156 61.
43. Chapman MJ, Nguyen NQ, Fraser RJ. Gastrointestinal motility and prokinetics in the critically ill. Curr. Opin. Crit. Care 2007 13 : 187 94.
44. Landzinski J, Kiser TH, Fish DN, Wischmeyer PE, MacLaren R. Gastric motility function in critically ill patients tolerant vs intolerant to gastric nutrition. JPEN J. Parenter. Enteral. Nutr. 2008 32 : 45 50.
45. Banh HL, MacLean C, Topp T, Hall R. The use of tegaserod in critically ill patients with impaired gastric motility. Clin. Pharmacol. Ther. 2005 77 : 583 6.
46. Stephens DP, Thomas JH, Collins SJ, Goldrick PB, Fowler S. A clinical audit of the efficacy of tegaserod as a prokinetic agent in the intensive care unit. Crit. Care Resusc. 2007 9 : 148 50.
47. Nguyen NQ, Chapman M, Fraser RJ, Bryant LK, Burgstad C, Holloway RH. Prokinetic therapy for feed intolerance in critically illness: one drug or two? Crit. Care Med. 2007 35 : 2561 7.
48. Ibero M, Ridao M, Artigas R, Martin B, Tresserras R. Cisapride treatment changes the evolution of infant asthma with gastroesophageal reflux. J. Investig. Allergol. Clin. Immunol. 1998 8 : 176 9.
49. Tucci F, Resti M, Fontana R, Novembre E, Lami CA, Vierucci A. Gastroesophageal reflux and bronchial asthma: prevalence and effect of cisapride therapy. J. Pediatr. Gastroenterol. Nutr. 1993 17 : 265 70.
50. Nolan P, Phillips M, Williamson B. Cisapride and brittle asthma. Lancet 1990 336 : 1443.
51. Jiang SP, Liang RY, Zeng ZY, Liu QL, Liang YK, Li JG. Effects of antireflux treatment on bronchial hyper-responsiveness and lung function in asthmatic patients with gastroesophageal reflux disease. World J. Gastroenterol. 2003 9 : 1123 5.
52. Sharma B, Sharma M, Daga MK, Sachdev GK, Bondi E. Effect of omeprazole and domperidone on adult asthmatics with gastroesophageal reflux. World J. Gastroenterol. 2007 13 : 1706 10.
53. Corrado G, D'Eufemia P, Pacchiarotti C et al. Irritable oesophagus syndrome as cause of chronic cough. Ital. J. Gastroenterol. 1996 28 : 526 30.
54. Poe RH, Kallay MC. Chronic cough and gastroesophageal reflux disease: experience with specific therapy for diagnosis and treatment. Chest 2003 123 : 679 84.
55. Saye Z, Forget PP. Effect of cisapride on esophageal pH monitoring in children with reflux-associated bronchopulmonary disease. J. Pediatr. Gastroenterol. Nutr. 1989 8 : 327 32.
56. Gupta VK. Metoclopramide aborts cough-induced headache and ameliorates cough-a pilot study. Int. J. Clin. Pract. 2007 61 : 345 8.
57. Petroianu G, Hein G, Petroianu A, Bergler W, Rufer R. Idiopathic chronic hiccup: combination therapy with cisapride, omeprazole, and baclofen. Clin. Ther. 1997 19 : 1031 8.
58. Duffy MC, Edmond H, Campbell K, Fulton JD. Hiccough relief with cisapride. Lancet 1992 340 : 1223.
59. Madanagopolan N. Metoclopramide in hiccup. Curr. Med. Res. Opin. 1975 3 : 371 4.
60. Launois S, Bizec JL, Whitelaw WA, Cabane J, Derenne JP. Hiccup in adults: an overview. Eur. Respir. J. 1993 6 : 563 75.
61. Stav A, Weksler N, Berman M et al. Premedication with metoclopramide decreases the frequency of methohexital induced hiccup. J. Anesth. 1992 6 : 17 20.
62. Pinczower GR. Stop those hiccups! Anesth. Analg. 2007 104 : 224.
63. Gupta VK. Metoclopramide for migraine-associated hiccup. Int. J. Clin. Pract. 2006 60 : 604 5.
64. Kluger MT, Willemsen G. Anti-aspiration prophylaxis in New Zealand: a national survey. Anaesth. Intensive Care 1998 26 : 70 7.
65. Orr DA, Bill KM, Gillon KR, Wilson CM, Fogarty DJ, Moore J. Effects of omeprazole, with and without metoclopramide, in elective obstetric anaesthesia. Anaesthesia 1993 48 : 114 19.
66. Pneumatikos J, Koulouras B, Frangides C, Goe D, Nakos G. Cisapride decreases gastric content aspiration in mechanically ventilated patients. Crit. Care 1999 3 : 39 43.
67. Pareek N, Williams J, Hanna D, Johnson WD, Minocha A, Abell TL. Prokinetic therapy reduces aspiration pneumonia in tube-fed patients with severe developmental disabilities. Am. J. Ment. Retard. 2007 112 : 467 71.
68. Sartori S, Trevisani L, Tassinari D et al. Prevention of aspiration pneumonia during long-term feeding by percutaneous endoscopic gastrostomy: might cisapride play any role? An open pilot study. Support. Care Cancer 1994 2 : 188 90.
69. He M, Ohrui T, Ebihara T, Ebihara S, Sasaki H, Arai H. Mosapride citrate prolongs survival in stroke patients with gastrostomy. J. Am. Geriatr. Soc. 2007 55 : 142 4.
70. Sandhu BS, Gupta R, Sharma J, Singh J, Murthy NS, Sarin SK. Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites. J. Gastroenterol. Hepatol. 2005 20 : 599 605.
71. Madrid AM, Hurtado C, Venegas M, Cumsille F, Defilippi C. Long-term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function. Am. J. Gastroenterol. 2001 96 : 1251 5.
72. Farup PG, Tjora S, Tholfsen JK. Effect of cisapride on symptoms and biliary drainage in patients with postcholecystectomy syndrome. Scand. J. Gastroenterol. 1991 26 : 945 50.
73. Veysey MJ, Malcolm P, Mallet AI et al. Effects of cisapride on gall bladder emptying, intestinal transit, and serum deoxycholate: a prospective randomized, double blind, placebo controlled trial. Gut 2001 49 : 828 34.
74. Dhiman RK, Reddi R, Sharma A et al. Cisapride improves gallbladder emptying and bile lipid composition in patients with gallstones. J. Gastroenterol. Hepatol. 2001 16 : 816 20.
75. Baxter PS, Maddern GJ. Effect of cisapride on gastroduodenal reflux and gall bladder motility in patients with gallstones. Dig. Surg. 1998 15 : 35 41.
76. Thorens J, Schnegg JF, Brignoli R et al. Effect of cisapride on gallbladder motility after extracorporeal shockwave lithotripsy. J. Hepatol. 1995 22 : 333 7.
77. Marchi S, Polloni A, Bellini M et al. Cisapride improves gallbladder kinetics in patients affected with myotonic muscular dystrophy. Int. J. Clin. Pharmacol. Res. 1993 13 : 53 8.
78. Ziegenhagen DJ, Heitz W, Kruis W, Pohl C, Zehnter E. Cisapride increases gallbladder volume in gallstone patients before and after extracorporeal shock wave lithotripsy. Aliment. Pharmacol. Ther. 1993 7 : 617 22.
79. von Kiedrowski R, Huijghebaert S, Raedsch R. Mechanisms of cisapride affecting gallbladder motility. Dig. Dis. Sci. 2001 46 : 939 44.
80. Horowitz M, Jones KL, Rayner CK, Read NW. 'Gastric' hypoglycaemia-an important concept in diabetes management. Neurogastroenterol. Motil. 2006 18 : 405 7.
81. Rayner CK, Jones KL, Samsom M, Horowitz M. Relationships of upper gastrointestinal motor and sensory function with glycemic conrol. Diabetes Care 2001 24 : 371 81.
82. Lysy J, Israeli E, Strauss-Liviatan N, Goldin E. Relationships between hypoglycaemia and gastric emptying abnormalities in insulin-treated diabetes patients. Neurogastroenterol. Motil. 2006 18 : 433 40.
83. Koshiyama H, Shimono D, Wada Y, Nakamura Y. Improvement of glycemic control after treatment with mosapride for diabetic gastropathy. Diabetes Care 2000 23 : 1198 9.
84. Asakawa H, Hayashi I, Fukui T, Tokunaga K. Effect of mosapride on glycemic control and gastric emptying in type 2 diabetes mellitus patients with gastropathy. Diabetes Res. Clin. Pract. 2003 61 : 175 82.
85. Ueno N, Inui A, Asakawa A et al. Mosapride, a 5HT-4 receptor agonist, improves insulin sensitivity and glycemic control in patients with type II diabetes mellitus. Diabetologia 2002 45 : 792 7.
86. Horowitz M, Jones KL, Harding PE, Wishart JM. Relationship between the effects of cisapride on gastric emptying and plasma glucose concentrations in diabetic gastroparesis. Digestion 2002 65 : 41 6.
87. Braden B, Enghofer M, Schaub M, Usadel KH, Caspary WF, Lembcke B. Long-term cisapride treatment improves diabetic gastroparesis but not glycaemic control. Aliment. Pharmacol. Ther. 2002 16 : 1341 6.
88. Wishart JM, Horowitz M, Campbell J, Jones KL. The effect of cisapride on oral and intravenous glucose tolerance in normal subjects. J. Gastroenterol. Hepatol. 1997 12 : 795 800.
89. Stewart WF, Shechter A, Rasmussen BK. Migraine prevalence: a review of population-based studies. Neurology 1994 44 (6 Suppl. 4 S17 23.
90. Desmond PV, Watson KJ. Metoclopramide-a review. Med. J. Aust. 1986 1442 : 366 90.
91. Hughes JB. Metoclopramide in migraine treatment. Med. J. Aust. 1977 2 : 580.
92. Tfelt-Hansen P, Olesen J, Aebelholt-Krabbe A, Melgaard B, Veilis B. A double blind study of metoclopramide in the treatment of migraine attacks. J. Neurol. Neurosurg. Psychiatry 1980 43 : 369 71.
93. Tek DS, McClellan DS, Olshaker JS, Allen CL, Arthur DC. A prospective, double-blind study of metoclopramide hydrochloride for the control of migraine in the emergency department. Ann. Emerg. Med. 1990 19 : 1083 7.
94. Coppola M, Yealy DM, Leibold RA. Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache. Ann. Emerg. Med. 1995 26 : 541 6.
95. Ellis GL, Delaney J, DeHart DA, Owens A. The efficacy of metoclopramide in the treatment of migraine headache. Ann. Emerg. Med. 1993 22 : 191 5.
96. Jones J, Pack S, Chun E. Intramuscular prochlorpezazine versus metoclopramide as single-agent therapy for the treatment of acute migraine headache. Am. J. Emerg. Med. 1996 14 : 262 4.
97. MacCumber MW, Jaffe GJ, McCuen BW 2nd. Treatment of migraine headache after ocular surgery with intravenous metoclopramide hydrochloride. Am. J. Ophthalmol. 1996 121 : 96 7.
98. Cameron JD, Lane PL, Speechley M. Intravenous chlorpromazine vs intravenous metoclopramide in acute migraine headache. Acad. Emerg. Med. 1995 2 : 597 602.
99. Friedman BW, Corbo J, Lipton RB et al. A trial metoclopramide vs sumatriptan for the emergency department treatment of migraines. Neurology 2005 64 : 463 8.
100. Gupta VK. Recurrent syncope, hypotension, asthma, and migraine with aura: role of metoclopramide. Headache 2005 45 : 1413 16.
101. Pryse-Phillips WE, Dodick DW, Edmeads JG et al. Guidelines for the diagnosis and management of migraine in clinical practice. Canadian Headache Society. CMAJ 1997 156 : 1273 87.
102. Colman I, Brown MD, Innes GD, Grafstein E, Roberts TE, Rowe BH. Parenteral metoclopramide for acute migraine: meta-analysis of randomized controlled trials. BMJ 2004 329 : 1369 73.
103. Haugh MJ, Lavender L, Jensen LA, Giulano R. An office-based double-blind comparison of dihydroergotamine versus dihydroergotamine/metoclopramide in thetreatment of acute migraine. Headache 1992 32 : 251.
104. Saadah HA. Abortive migraine therapy with oral naproxen sodium plus metoclopramide plus ergotamine tartrate with caffeine. Headache 1992 32 : 95 7.
105. Chabriat H, Joire JE, Danchot J, Grippon P, Bousser MG. Combined oral lysine acetylsalicylate and metoclopramide in the acute treatment of migraine: a multicentre double-blind placebo-controlled study. Cephalalgia 1994 14 : 297 300.
106. Tfelt-Hansen P, Henry P, Mulder LJ, Scheldewaert RG, Schoenen J, Chazot G. The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine. Lancet 1995 346 : 923 6.
107. Tfelt-Hansen P. The effectiveness of combined oral lysine acetylsalicylate and metoclopramide (Migpriv) in the treatment of migraine attacks. Comparison with placebo and oral sumatriptan. Funct. Neurol. 2000 15 (Suppl. 3 196 201.
108. Schlman EA, Dermott KF. Sumatriptan plus metoclopramide in triptan-nonresponsive migraineurs. Headache 2003 43 : 729 33.
109. Oldman AD, Smith LA, McQuay HJ, Moore RA. Pharmacological treatments for acutemigraine: quantitative systematic review. Pain 2002 97 : 247 57.
110. Klapper JA, Stanton JS. Ketorolac versus DHE and metoclopramide in the treatment of migraine headaches. Headache 1991 31 : 523 4.
111. Klapper JA, Stanton J. Current emergency treatment of severe migraine headaches. Headache 1993 33 : 560 2.
112. Scherl ER, Wilson JF. Comparison of dihydroergotamine with metoclopramide versus meperidine with promethazine in the treatment of acute migraine. Headache 1995 35 : 256 9.
113. Edwards KR, Norton J, Behnke M. Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache. Headache 2001 41 : 976 80.
114. Geraud G, Compagnon A, Rossi A. Zolmitriptan versus a combination of acetylsalicylic acid and metoclopramide in the acute oral treatment of migraine: a double-blind, randomized, three-attack study. Eur. Neurol. 2002 47 : 88 98.
115. Azzopardi TD, Brooks NA. Oral metoclopramide as an adjunct to analgesics for the outpatient treatment of acute migraine. Ann. Pharmacother. 2008 42 : 397 402.
116. Cete Y, Dora B, Ertan C, Ozdemir C, Oktay C. A randomized prospective placebo-controlled study of intravenous magnesium sulphate vs. metoclopramide in the management of acute migraine attacks in the Emergency Department. Cepharalgia 2005 25 : 199 204.
117. MacGregor EA, Wilkinson M, Bancroft K. Domperidone plus paracetamol in the treatment of migraine. Cepharalgia 1993 13 : 124 7.
118. Victor S, Ryan SW. Drugs for preventing migraine headaches in children. Cochrane Database Syst. Rev. 2003 4 CD002761.
119. Sempere AP, Duarte J, Cabezas C, Claveria LE, Coria F. Aggravation of parkisonian tremor by cisapride. Clin. Neuropharmacol. 1995 18 : 76 8.
120. Dialdetti R, Koren M, Ziv I, Achiron A, Melamed E. Effect of cisapride on response fluctuations in Prkinson's disease. Mov. Disord. 1995 10 : 81 4.
121. Neira WD, Sanchez V, Mena MA, de Yebenes JG. The effect of cisapride on plasma L-dopa levels and clinical response in Parkinson's disease. Mov. Disord. 1995 10 : 66 70.
122. 4 agonist therapy reduces response fluctuations in Parkinson's disease. Parkinsonism Relat. Disord. 2005 11 : 499 502.
123. Djaldetti R, Melamed E. Management of response fluctuations: practical guidelines. Neurology 1998 51 (2 Suppl. 2 S36 40.
124. De Caprio C, Pasanisi F, Contaldo F. Gastrointestinal complications in a patient with eating disorders. Eat. Weight Disord. 2000 5 : 228 30.
125. Stacher G, Peeters TL, Bergmann H et al. Erythromycin effects on gastric emptying, antral motility and plasma motilin and pancreatic polypeptide concentratons in anorexia nervosa. Gut 1993 34 : 166 72.
126. Stacher G, Abartzi-Wenzel TA, Wiesnagrotzki S, Bergmann H, Schneider C, Gaupmann G. Gastric emptying, body weight and symptoms in primary anorexia nervosa. Long-term effects of cisapride. Br. J. Psychiatry 1993 162 : 398 402.
127. Szmukler GI, Young GP, Miller G, Lichtenstein M, Binns DS. A controlled trial of cisapride in anorexia nervosa. Int. J. Eat. Disord. 1995 17 : 347 57.
128. Jimenez-Jimenez FJ, Garcia-Ruiz PJ. Pharmaccological options for the treatment of Tourette's disorder. Drugs 2001 61 : 2207 20.
129. Desai AB, Doongaji DR, Satoskar RS. Metoclopramide in Gilles de la Tourette's syndrome (a case report). J. Postgrad. Med. 1983 29 : 181 3.
130. Acosta MT, Castellanos FX. Use of the 'inverse neuroleptic' metoclopramide in Tourette syndrome: an open case series. J. Child Adolesc. Psychopharmacol. 2004 14 : 123 8.
131. Smirnov AIU. Use of metoclopramide (cerucal) in Tourette syndrome. Zh Neuropatol. Psikhiartr. Im S S Korsakova 1989 89 : 105 8.
132. Nicolson R, Craven-Thuss B, Smith J, Mckinlay D, Castellanos FX. A randomized, double-blind, placebo-controlled trial of metoclopramide for the treatment of Tourette's disorder. J. Am. Acad. Child Adolesc. Psychiatry 2005 44 : 640 6.
133. Chaudhuri TK, Fink S, Burger R, Palmer JDK. The effect of metoclopramide treatment on diabetic cystopraresis. JAMA 1988 259 : 1646.
134. Nestler JE, Stratton MA, Hakim CA. Effect of metoclopramide on diabetic neurogenic bladder. Clin. Pharm. 1983 2 : 83 5.
135. Franceschetti GP, Candura SM, Vicini D, Tonini M. Cisapride enhances detrusor contractility and improves micturition in a woman with lazy bladder. Scand. J. Urol. Nephrol. 1997 31 : 209 10.
136. Steele AC, Walsh P, Bentley M, Neff J, Karram M. A randomized, double-blind placebo-controlled trial of the effects of the 5- hydroxytriptamine(4) agonist cisapride on the female urinary bladder. Am. J. Obstet. Gynecol. 2001 185 : 62 4.
137. Etienne M, Verlinden M, Brassinne A. Treatment with cisapride of the gastrointestinal and urological sequelae of spinal cord transection: case report. Paraplegia 1988 26 : 162 4.
138. Carone R, Vercelli D, Bertapelle P. Effects of cisapride on anorectal and vesicourethral function in spinal cord injured patients. Paraplegia 1993 31 : 125 7.
139. Wyndaele JJ, Van Kerrebroeck P. The effects of 4 weeks treatment with cisapride on cystometric parameters in spinal cord injury patients. A double-blind, placebo controlled study. Paraplegia 1995 33 : 625 7.
140. Madeiro AP, Rufino AC, Sartori MGF, Baracat EC, De Lima GR, Girao MJBC. The effects of bethanechol and cisapride on urodynamic parameters in patients undergoing radical hysterectomy for cervical cancer. A ranodomized, double-blind, placebo-controlled study. Int. Urogynecol. J. 2006 17 : 248 52.
141. Mendes MC, Ferriani RA, Sala MM, Moura MD, de Sa MF. Induction of ovulation with clomiphene citrate in combination with metoclopramide in patients with amenorrhea of hypothalamic origin. Gynecol. Endoscrinol. 1999 13 : 149 54.
142. Jordan B, Heine RG, Meehan M, Catto-Smith AG, Lubits L. Effect of antireflux medication, placebo and infant mental health intervention on persistent crying: a randomized clinical trial. J. Pediatr. Child Health 2006 42 : 49 58.
143. Vandenplas Y, Denever M, Verlinden M, Aerts T, Sacre L. Gastroesophageal reflux incidence and respiratory dysfunction during sleep in infants: treatment with cisapride. J. Pediatr. Gastroenterol. Nutr. 1989 8 : 31 6.
144. Kohl M, Wuerdemann I, Clemen J, Iven H, Katalinic A, Moeller JC. Cisapride may improve feeding tolerance of preterm infants: a randomized placebo-controlled trial. Biol. Neonate 2005 88 : 270 5.
145. Meadow WL, Bui KC, Strates E, Dean R. Metoclopramide promotes enteral feeding in preterm infants with feeding intolerance. Dev. Pharmacol. Ther. 1989 13 : 38 45.
146. Boris M, Goldblatt A, Krigsman A. Laryngeal dysfunction: a common cause of respiratory distress, often misdiagnosed as asthma and responsive to antireflux therapy. Allergy Asthma Proc. 2002 23 : 133 9.
147. Budd SC, Erdman SH, Long DM, Trombley SK, Udall JN Jr. Improved lactation with metoclopramide. A case report. Clin. Pediatr. 1993 32 : 53 7.
148. Hansen WF, McAndrew S, Harris K, Zimmerman MB. Metoclopramide effect on breastfeeding the preterm infant: a randomized trial. Obstet. Gynecol. 2005 105 : 383 9.
149. Seema, Patwari AK, Satyanarayana L. Relactation: an effective intervention to promote exclusive breastfeeding. J. Trop. Pediatr. 1997 43 : 213 16.